INTERCOMMISSURAL LEAFLET SUPPORT
20230363912 ยท 2023-11-16
Inventors
Cpc classification
International classification
A61F2/24
HUMAN NECESSITIES
Abstract
An anchor is anchorable to tissue of a ventricle downstream of a heart valve of a subject. Each wing of a pair of wings defines a lateral surface and a medial surface, such that the medial surface of one wing of the pair faces the medial surface of the other wing of the pair. The wings are coupled to the anchor such that, when the anchor is anchored to the tissue, the anchor supports the wings at the valve, with the lateral surface of each wing facing a respective leaflet of the valve. During systole, the lateral surface of each wing is in contact with the respective leaflet, and the medial surfaces of the wings move into contact with each other, obstructing retrograde blood flow. During diastole, the medial surfaces move out of contact with each other, facilitating antegrade blood flow. Other implementations are also described.
Claims
1. A system for use with a valve of a heart of a subject, the heart cycling between systole and diastole, and the system comprising a leaflet support, the leaflet support comprising: a tissue anchor, anchorable to ventricular tissue of a ventricle that is downstream of the valve; and a pair of wings, each wing of the pair defining: a medial surface, such that the medial surface of one wing of the pair faces the medial surface of the other wing of the pair, and a lateral surface, wherein the pair of wings is coupled to the tissue anchor such that, when the tissue anchor is anchored to the ventricular tissue, the tissue anchor flexibly supports the pair of wings at the valve, with the lateral surface of each wing of the pair facing a respective leaflet of the valve such that: during systole: the lateral surface of each wing of the pair is in contact with the respective leaflet, and the medial surfaces of the wings of the pair move into contact with each other, thereby obstructing retrograde blood flow through the valve, and during diastole, the medial surfaces of the wings move out of contact with each other, thereby facilitating antegrade blood flow through the valve.
2. The system according to claim 1, wherein the lateral surface comprises an entire area of the wing.
3. The system according to claim 1, wherein the leaflet support has a delivery state in which the leaflet support is configured to be transluminally advanceable to the valve.
4. The system according to claim 1, wherein the pair of wings is a first pair of wings, and wherein the leaflet support further comprises a second pair of wings.
5. The system according to claim 4, wherein the leaflet support further comprises a third pair of wings.
6. The system according to claim 1, wherein the pair of wings is configured such that, when the tissue anchor is anchored to the ventricular tissue, each wing of the pair remains in contact with its respective leaflet during diastole.
7. The system according to claim 6, wherein the pair of wings is configured such that, when the tissue anchor is anchored to the ventricular tissue, the lateral surface of each wing of the pair remains in contact with its respective leaflet during diastole.
8. The system according to claim 1, wherein the leaflet support further comprises a flexible frame, and each wing of the pair is fixed upon the frame.
9. The system according to claim 8, wherein the frame is elastically deformable.
10. The system according to claim 9, wherein the frame is configured to bias the wings of the pair away from each other.
11. The system according to claim 10, wherein the frame is sufficiently flexible that the wings of the pair can be pushed into contact with each other by a total converging force of less than 30 g.
12. The system according to claim 11, wherein the frame is sufficiently flexible that the wings of the pair can be pushed into contact with each other by a total converging force of less than 20 g.
13. The system according to claim 12, wherein the frame is sufficiently flexible that the wings of the pair can be pushed into contact with each other by a total converging force of less than 10 g.
14. The system according to claim 13, wherein the frame is sufficiently flexible that the wings of the pair can be pushed into contact with each other by a total converging force of 0.1-10 g.
15. The system according to claim 14, wherein the frame is sufficiently flexible that the wings of the pair can be pushed into contact with each other by a total converging force of 1-10 g.
16. The system according to claim 13, wherein the frame is sufficiently flexible that the wings of the pair can be pushed into contact with each other by a total converging force of less than 5 g.
17. The system according to claim 1, wherein each wing of the pair comprises an integrin-binding ligand.
18. The system according to claim 17, wherein each wing of the pair comprises at least one of fibronectin, vitronectin, collagen, and laminin.
19. The system according to claim 1, wherein each wing of the pair comprises a material that is impermeable to blood.
20. The system according to claim 1, wherein each wing of the pair comprises pericardial tissue.
21. The system according to claim 1, wherein each wing of the pair comprises a fabric.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0084]
[0085]
DETAILED DESCRIPTION
[0086] Reference is made to
[0087] Leaflet support 20 comprises a pair of wings 22 (e.g., a first wing 22a and a second wing 22b), which are coupled to each other such that, when leaflet support is implanted in heart 90, (i) during systole, the medial surfaces of the wings of the pair move into contact with each other, thereby obstructing retrograde blood flow through the valve, and (ii) during diastole, the medial surfaces of the wings move out of contact with each other, thereby facilitating antegrade blood flow through the valve. For example, and as shown as in
[0088] For some applications, and as shown, wings 22 are positioned such that each wing has a medial surface 26 facing the medial surface of the other wing, as well as a lateral surface 24 facing away from the other wing. For some such applications, and as shown, wings 22 can be shaped as contoured sheets that curve apart from each other as they extend (e.g., as they extend upstream) along a respective contour of leaflets 61, 63. For example, an upstream inter-wingspan d1 between upstream ends of the wings, can be greater than a downstream inter-wingspan d2 between downstream ends of the wings.
[0089] For some applications, and as shown, support 20 further comprises a tissue anchor 40 (e.g., a pair of tissue anchors 40a, 40b). Often for such applications, support 20 is coupled to the anchor 40 such that the anchor flexibly supports wings 22 at valve 60. For some applications (not shown), anchors 40 are coupled directly to frame 30 of support 20. For some applications, and as shown, a rod 42 is used to couple wings 22 to anchors 40. For some applications (not shown), frame 30 comprises a hinge (e.g., by a hinge coupling the frame to anchor 40 and/or to rod 42).
[0090] For some applications, and as shown, wings 22 are fixed upon flexible frame (e.g., wire) 30, such that the frame serves as a scaffolding for the wings. Wings 22 can be comprised of a material that has greater flexibility than the frame, and therefore the wings can generally assume a shape defined by the frame. For example, and as shown, frame 30 can be secured along one or more edges of wings 22. Alternatively or in addition, it may be desirable for frame 30 to support wings 22 between the edges.
[0091] For some applications, frame 30 is elastically deformable (e.g., comprising an elastic, superelastic, or shape-memory material such as Nitinol), and is biased to maintain wings 22 apart in the absence of force applied thereto. For some such applications, frame 30 is sufficiently flexible that wings 22 can be pushed into contact with each other by forces experienced during systole (e.g., forces applied by blood and/or leaflets 61, 63). For example, frame 30 can be sufficiently flexible that wings 22 can be pushed into contact with each other (e.g., during systole) by a total medial pushing (i.e., converging) force of less than 30 g (e.g., less than 20 g, e.g., less than 10 g, e.g., less than 5 g) and/or greater than 0.1 g (e.g., greater than 1 g), e.g., 0.1-30 g (e.g., 0.1-20 g, 0.1-10 g, e.g., 0.1-5 g) or 1-30 g (e.g., 1-20 g, e.g., 1-10 g, e.g., 1-5 g). It is hypothesized that such a configuration facilitates maintenance of contact between leaflets 61, 63 and wings 22 while the heart cycles from diastole to systole.
[0092]
[0093] For some applications, wings 22 and leaflets 61, 63 move in tandem (e.g., toward each other and away from each other) while the heart cycles between diastole (left frame of
[0094] Whereas leaflets of a prosthetic heart valve typically contact each other at the edges of the leaflets, for some applications, medial surfaces 26 of wings 22 contact each other on faces of the wings, but not at edges of the wings.
[0095] It is typically desirable that wings 22 facilitate antegrade (downstream) blood flow (e.g., from left atrium 62 to left ventricle 64, through mitral valve 60), during diastole (indicated by arrows in left frame of
[0096] For some applications, each wing 22 (e.g., lateral surface 24 thereof) remains in contact with its respective leaflet 61, 63 during diastole. For some such applications, elasticity of the frame is such that, while wings 22 are positioned between leaflets 61, 63, the wings apply mild a lateral pushing force against the leaflets, thereby maintaining the wings (e.g., lateral surfaces 24 thereof) in contact with the leaflets. It is hypothesized that wings 22 contacting the leaflets during diastole serves to reduce obstruction of antegrade blood flow by the wings.
[0097] For some applications, maintenance of contact between lateral surfaces 24 and respective leaflets during diastole is facilitated by affixing lateral surfaces 24 to leaflets 61, 63. For example, a staple can be used to staple each wing to a leaflet. Alternatively or in addition, an adhesive can be used to adhere the lateral surfaces to the leaflets. Alternatively still, or in addition, lateral surfaces 24 can comprise a material that encourages growth of tissue of leaflets 61, 63 into the lateral surfaces. For example, lateral surfaces 24 can comprise a fabric such as a polyester (e.g., polyethylene terephthalate) fabric, and/or an integrin-binding ligand (e.g., fibronectin, vitronectin, collagen and/or laminin).
[0098] For some applications, wings 22 are dimensioned to avoid obstruction of antegrade blood flow during diastole. For example, each entire wing 22 can be disposed flat against its respective leaflet 61, 63 (e.g., lateral surface comprises an entire area of wing 22) while the support is anchored to the ventricular tissue. In this way, wings 22 may not be anticipated to obstruct antegrade blood flow significantly more than do the leaflets.
[0099] For some applications, during systole, coaptation between medial surfaces 26 of wings 22 closes support 20 to blood flow therethrough. It is hypothesized that contact between (i) lateral surface 24a and anterior leaflet 61, (ii) lateral surface 24b and posterior leaflet 63, and (iii) respective medial surfaces 26a and 26b, each alone and in tandem, obstructs retrograde blood flow through mitral valve 60 during systole. It is further hypothesized that obstructing retrograde blood flow through mitral valve 60 during systole may facilitate antegrade blood flow through aortic valve 70 into aorta 72 (as indicated by arrows in right frame of
[0100] For some applications, wings 22 comprise material that is impermeable to blood. For some applications, wings 22 comprise pericardial tissue. It is hypothesized that such materials may facilitate obstruction of retrograde blood flow through mitral valve 60 during systole.
[0101] For some applications, support 20 is dimensioned such that each wing 22 extends from a first commissure to a second commissure of the valve (e.g., from an anterior commissure of mitral valve 60 to a posterior commissure of the mitral valve). It is hypothesized that each wing of support 20 extending from commissure to the commissure facilitates obstruction of retrograde blood flow through by the support more effectively than if wings 22 were to extend only partly between commissures.
[0102] Reference is made to
[0103] Similar to support 20 described hereinabove, support 120 is shown being used to facilitate coaptation of mitral valve 60, yet this description is not meant to exclude use of support 120 to facilitate coaptation of other valves of the heart, mutatis mutandis.
[0104] As shown in
[0105] Support 120 shares some features with support 20 described hereinabove. Particularly, coaptation element 122 shares some commonalities with wing 22 (However, in contrast to support 20 which comprises a pair of wings, support 120 comprises a single coaptation element 122). For instance, coaptation element 122 can comprise a frame (e.g., comprising a shape-memory material) 130 which serves as a scaffolding that defines a shape of the coaptation element. For some such applications, and as shown in
[0106] For some applications, and similarly to as described hereinabove in reference to lateral surfaces 24 of wings 22 of support 20, first leaflet-contacting surface 124 comprises material that encourages growth of tissue (e.g., tissue of posterior leaflet 63) positioned into the first leaflet-contacting surface. For example, first leaflet-contacting surface 124 can comprise a fabric such as a polyester (e.g., polyethylene terephthalate) fabric, and/or an integrin-binding ligand (e.g., fibronectin, vitronectin, collagen and/or laminin).
[0107] As shown in
[0108] As described hereinabove in reference to wings 22 of support 20, coaptation element 122 can extend from the anterior commissure of mitral valve 60 to the posterior commissure of the mitral valve. It is hypothesized that coaptation element 122 extending from the anterior commissure to the posterior commissure impedes retrograde blood flow through mitral valve 60 during systole, more effectively than would support 120 if the coaptation element were to extend only partly between commissures.
[0109]
[0110] For some applications, e.g., for applications in which fixator 128 is disposed downstream of mitral valve 60, fixator 128 can be substituted by a tissue anchor, e.g., tissue anchors 40, sharing the same features as described hereinabove with respect to
[0111] For some applications, the expansion of fixator 128 can press posterior leaflet 63 against coaptation element 122 (e.g., against first leaflet-contacting surface 124 thereof), and/or can push the posterior leaflet toward anterior leaflet 61. It is hypothesized that, for some applications, this may facilitate coaptation of anterior leaflet 61 with coaptation element 122 during systole.
[0112] For some applications, fixator 128 passively fills with blood upon implantation at the implantation site. For some such applications, fixator 128 filling with blood facilitates securing fixator 128 to the implantation site (e.g., by increasing a volume of the fixator, thereby increasing contact between the fixator and the implantation site). For some such applications, fixator 128 comprises an absorbent material. For some such applications, the absorbent material filling with blood facilitates clotting of the blood within fixator 128, and/or tissue growth on the fixator. For example, clotting of the blood within fixator 128, while the fixator contacts the posterior leaflet 63, may serve to fixate the posterior leaflet.
[0113] Alternatively or in addition to comprising absorbent material, fixator 128 can further comprise a self-expanding structure. For example, nonabsorbent fixator 128 can comprise a shape-memory spring or other structure.
[0114] The present invention is not limited to the examples that have been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description. Further, the techniques, methods, operations, steps, etc. described or suggested herein can be performed on a living animal or on a non-living simulation, such as on a cadaver, cadaver heart, simulator (e.g., with the body parts, tissue, etc. being simulated), etc.